Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68788-4133

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68788-4133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron Odt Tablets 8mg (Cartonodt8mg10s)

Packaging label for Ondansetron ODT Tablets 8mg orally disintegrating tablets by Glenmark Pharmaceuticals Limited. The label includes dosage information, storage instructions at 20°-25°C, cautionary statements, and bilingual dosing directions in English and Spanish. The labeler is Preferred Pharmaceuticals Inc. Barcodes and placeholders for lot, batch, and expiration date are also present.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing its molecular framework with specific functional groups and bonds relevant to the active pharmaceutical ingredient.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing its molecular composition including indole, ketone, and methyl-substituted imidazole groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.